<?xml version="1.0" encoding="UTF-8"?>
<p>Patients with severe COVID-19 were included (
 <xref rid="B45" ref-type="bibr">45</xref>). These patients had at least one of the following conditions: (i) hypoxemia (need for noninvasive or invasive respiratory support to provide capillary oxygen saturation above 90%), (ii) hypotension (systolic blood pressure less than 90â€‰mm Hg or vasopressor requirement), (iii) renal failure secondary to COVID-19 (according to KDIGO definition) (
 <xref rid="B46" ref-type="bibr">46</xref>), (iv) neurologic disorder secondary to COVID-19 (decrease of 2 or more scores on the Glasgow Coma Scale), (v) thrombocytopenia secondary to COVID-19 (platelet count less than 150,000/mm
 <sup>3</sup>), and (vi) severe gastrointestinal symptoms secondary to COVID-19 (vomiting/diarrhea that caused at least mild dehydration).
</p>
